)
)
Corline Biomedical Investor Relations Material
Latest events
Q2 2024
Corline Biomedical
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Corline Biomedical
Access all reports
Corline Biomedical AB is a Swedish biotechnology company focused on developing heparin-based medical solutions to improve outcomes in kidney transplantation and cell therapies. The company’s proprietary Corline Heparin Conjugate (CHC) technology is central to its product offerings. Key products include Renaparin, aimed at improving kidney transplantation by reducing complications during surgery, and Cytoparin, designed for cell therapy applications, particularly in the treatment of type 1 diabetes. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
CLBIO
Country
🇸🇪 Sweden